Investment bank Goldman Sachs is pushing back on all-bro, all-white boards in 2020.
“We’re not going to take a company public unless there’s at least one diverse board candidate, with a focus on women,” Goldman CEO David Solomon told CNBC at the World Economic Forum in Davos, adding that that companies with female directors fared “significantly better” in their public debuts than those without. To wit, WeWork launched its bid to go public, backed by Goldman, with an all-male board. We all know that didn’t end well. (WeWork, by the way, still has an all-male board.)
The new policy kicks in this July in the U.S. and Europe, the bank chief said, which technically explains why Goldman is underwriting the IPO of one of the seven companies that have filed to go public in 2020 with all-male boards, Arcutis Biotherapeutics. But it’s still a puzzling move given the bank’s new diversity mandate and raises questions about its commitment to bringing more women into the boardroom.
“We don’t have a comment on specific companies but would just say that we have made a commitment that we will not take any company public in the United States and Europe that doesn’t have at least one diverse Director at the time of IPO and that we intend to work with our clients in order for them to achieve and potentially surpass these targets,” a spokesperson for Goldman said via email.
Since Arcutis, a pharmaceutical company, is headquartered in California it is legally obligated to have a female director — or face a $100,000 fine — before it goes public, so presumably Arcutis will be amending its IPO filing to add at least one female director. The company’s IPO is scheduled for Jan. 31, according to NASDAQ’s calendar. “We are focused on recruiting qualified female executives and directors not only to comply with California’s laws regarding board diversity, but more importantly because our board and leadership team see a need for the biotechnology industry to better utilize the talents and potential of women in our industry, particularly as they have been historically underrepresented at senior levels of biotech,” said Arcutis CEO Frank Watanabe in an emailed statement, adding that the company is in active discussions with several female board candidates.
Starting in 2021, Goldman will mandate a minimum of two diverse board directors. The bank itself, which underwrote more IPOs in 2019 than any other firm, has four women on its 11-person board. Goldman’s move puts pressure on its top rivals Morgan Stanley and JPMorgan Chase to follow suit. Last year, investment firm BlackRock voted against directors at more than 50 companies with boards that were not diverse with regard to gender, ethnicity, age and other criteria.
Originally published Friday, Jan. 24 at 10 a.m.; updated with comment from Goldman Sachs at 12:15 p.m. and with comment from Arcutis on Sunday, Jan. 26.
Aimee Stephens, subject of landmark Supreme Court case on trans civil rights, dies at 59
Aimee Stephens, the woman at the center of a pending landmark Supreme Court case regarding workplace legal protections for trans...
📈IPO📉Watch🔎 Q1 2020: Just 16% of board directors are women
While buzzy IPOs like Airbnb and DoorDash are tabled for the foreseeable, because pandemic, there’s still a slow trickle of...
Under 10% of the 220 leaders on Trump’s ‘Opening Our Country Council’ are women
We all speak percentage fluently now, and we’ve all grown sadly accustomed to dismal numbers, so here are some more:...
The RBG Way: The (many) secrets of Ruth Bader Ginsburg’s Success
It is 1959, and 26-year-old Ruth Bader Ginsburg is having trouble getting a job. She’s already attended Harvard Law School,...
Dissecting the soap opera unfurling at one of the world’s biggest law firms – updated
It has not been a good year of PR for Jones Day on the gender bias front — nor, more...
Lip service? WeWork’s new leader talks gender diversity at all-hands meeting (led by men, btw)
Bravo, Employee 7 from WeWork’s marketing department, who stepped up at the very widely reported all-hands meeting this week to...